市場調查報告書

玻糖醛酸酶的全球市場:2020-2026年

Global Hyaluronidase Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949661
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
玻糖醛酸酶的全球市場:2020-2026年 Global Hyaluronidase Market 2020-2026
出版日期: 2020年06月27日內容資訊: 英文
簡介

全球玻糖醛酸酶的市場在預測期間內預計大幅度成長。美容外科手術的增加,癌症的盛行率增加,中年人人口的全球增加等要素促進該市場的成長。各類型中,動物來源的玻糖醛酸酶對市場成長有大幅貢獻。各地區中,預計北美地區佔大幅佔有率。

本報告提供全球玻糖醛酸酶的市場調查,市場定義和概要,市場成長的各種影響因素分析,相關法律,市場規模的變化、預測,類型、用途等各種區分的明細,各地區、主要國家的詳細分析,競爭環境,企業佔有率,主要企業簡介等資訊彙整。

第1章 報告概要

第2章 市場概要、考察

  • 調查範圍
  • 分析師的見解、目前市場趨勢
  • 法律規章

第3章 競爭情形

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析

第4章 市場影響因素

  • 成長推動因素
  • 阻礙成長要素
  • 市場機會

第5章 市場分析、預測:各種區分

  • 各類型
    • 動物來源
    • 合成
  • 各用途
    • 化療
    • 皮膚科
    • 眼科
    • 其他(體外受精)

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • ALTEOGEN Inc.
  • Amphastar Pharmaceuticals, Inc.
  • Bausch Health Companies Inc.
  • Fox Group International
  • Gynemed GmbH & Co. KG
  • Halozyme, Inc.
  • Janssen Biotech, Inc.
  • Kitazato Corp.
  • Merck KGaA
  • Shreya Life Sciences Pvt. Ltd.
  • STEMCELL Technologies Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • The Cooper Companies Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • Vitrolife Sweden AB
目錄
Product Code: OMR2021980

Global Hyaluronidase Market Size, Share & Trends Analysis Report by Type (Animal-Derived Hyaluronidase and Synthetic Hyaluronidase) and by Application (Dermatology, Chemotherapy, Ophthalmology, and Others) and Forecast 2020-2026

The global hyaluronidase market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the rising cosmetic procedures, increasing prevalence of cancer, and rise in middle-aged population across the globe. The hyaluronidase market is classified on the basis of type and application. Based on type, the market is segmented into animal-derived hyaluronidase and synthetic hyaluronidase. Among these, the animal-derived hyaluronidase contributes significantly in the market growth across the globe. The majority of the approved brands of hyaluronidase are made of animal sources, which includes porcine and bovine. Based on application, the market is segregated into dermatology, chemotherapy, ophthalmology, and others. Among these applications, the hyaluronidase market is driven by its wide and growing application in dermatology. With the growing aesthetic concern in developed and emerging economies, the market for hyaluronidase in dermatology application is expected to project a considerable CAGR during the forecast period.

Geographically, the global hyaluronidase market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The US with a highly matured and well-developed healthcare infrastructure, contributes considerably in the hyaluronidase market. The prevalence of cancer is high in the US and the number of cosmetic procedures is significantly increasing, which in turn, is offering growth to the hyaluronidase market in North America. In addition, Asia-Pacific is expected to project a considerable growth during the forecast period. This growth is backed by the rising middle-aged population and medical tourism, especially in India, China, Malaysia, and Singapore.

The global hyaluronidase market is influenced by product development and advancements conducted by the market players. The key players of the hyaluronidase market include Amphastar Pharmaceuticals, Inc., Halozyme, Inc., STEMCELL Technologies Inc., Kitazato Corp., Gynemed GmbH & Co. KG, ALTEOGEN Inc., and Bausch Health Companies Inc. These players are playing a significant role in the growth of the hyaluronidase market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global hyaluronidase market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Hyaluronidase Market Research and Analysis by Type

2. Global Hyaluronidase Market Research and Analysis by Application

The Report Covers:

  • Comprehensive research methodology of the global hyaluronidase market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global hyaluronidase market.
  • Insights about market determinants which are stimulating the global market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Hyaluronidase Market by Type
    • 5.1.1. Animal-derived Hyaluronidase
    • 5.1.2. Synthetic Hyaluronidase
  • 5.2. Global Hyaluronidase Market by Application
    • 5.2.1. Chemotherapy
    • 5.2.2. Dermatology
    • 5.2.3. Ophthalmology
    • 5.2.4. Others (In Vitro Fertilization)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. ALTEOGEN Inc.
  • 7.2. Amphastar Pharmaceuticals, Inc.
  • 7.3. Bausch Health Companies Inc.
  • 7.4. Fox Group International
  • 7.5. Gynemed GmbH & Co. KG
  • 7.6. Halozyme, Inc.
  • 7.7. Janssen Biotech, Inc.
  • 7.8. Kitazato Corp.
  • 7.9. Merck KGaA
  • 7.10. Shreya Life Sciences Pvt. Ltd.
  • 7.11. STEMCELL Technologies Inc.
  • 7.12. Takeda Pharmaceutical Co. Ltd.
  • 7.13. The Cooper Companies Inc.
  • 7.14. Tokyo Chemical Industry Co., Ltd.
  • 7.15. Vitrolife Sweden AB

LIST OF TABLES

  • 1. GLOBAL HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL ANIMAL-DERIVED HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL SYNTHETIC HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 5. GLOBAL HYALURONIDASE IN CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL HYALURONIDASE IN DERMATOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL HYALURONIDASE IN OPHTHALMOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 8. GLOBAL OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 10. NORTH AMERICAN HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 11. NORTH AMERICAN HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 12. NORTH AMERICAN HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 13. EUROPEAN HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 14. EUROPEAN HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 15. EUROPEAN HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 16. ASIA-PACIFIC HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 17. ASIA-PACIFIC HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 18. ASIA-PACIFIC HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 19. REST OF THE WORLD HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 20. REST OF THE WORLD HYALURONIDASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HYALURONIDASE MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL HYALURONIDASE MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
  • 3. GLOBAL HYALURONIDASE MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. US HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. ROE HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF THE WORLD HYALURONIDASE MARKET SIZE, 2019-2026 ($ MILLION)